收藏切换
A collaborative study to evaluate the NB2-11 cell proliferation bioassay for human recombinant growth hormone
收藏切换
PDF
Xiao-ming ZHANG1, 2, He-yang LI1, 2, Zhe DENG3, Nai-song QI4, Xi WU5, Yi LI1, 2, Lü-yin WANG1, 2, Ping LÜ1, 2, Cheng-gang LIANG1, 2, Jing LI1, 2, *
Acta Pharmaceutica Sinica | 2025, 60(3) : 784 - 790
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(3): 784-790
Original Articles
A collaborative study to evaluate the NB2-11 cell proliferation bioassay for human recombinant growth hormone
Full
Xiao-ming ZHANG1, 2, He-yang LI1, 2, Zhe DENG3, Nai-song QI4, Xi WU5, Yi LI1, 2, Lü-yin WANG1, 2, Ping LÜ1, 2, Cheng-gang LIANG1, 2, Jing LI1, 2, *
Affiliations
  • 1. NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, National Institutes for Food and Drug Control, Beijing 102629, China
  • 2. State Key Laboratory of Drug Regulatory Science, Beijing 102629, China
  • 3. College of Life Science, Jilin University, Changchun 130012, China
  • 4. Henan Institute for Drug and Medical Device Inspection, Henan Vaccine Issuance Center, Zhengzhou 450008, China
  • 5. Shenzhen Institute for Drug Control, Shenzhen 518057, China
Published: 2025-03-12 doi: 10.16438/j.0513-4870.2024-0985
Outline
收藏切换

To explore the standardization of the in vitro Nb2-11 cell proliferation bioassay for recombinant human growth hormone (rhGH), we first tested the biological activity of 2 batches of rhGH drug substances, 3 batches of rhGH for injection, and 24 batches of rhGH injections, based on which we proposed the experimental effective criteria. Furthermore, we conducted methodological validation in accordance with General Rule 9401 of the 2020 edition of the Pharmacopoeia of the People's Republic of China. Subsequently, the inter-laboratory consistency, intra-laboratory and inter-laboratory precision of seven labs were studied by determining the in vitro bioactivity of six batches of rhGH products and two batches of rhGH drug substances from four different manufacturers using this method. The consistency of the in vitro and in vivo bioassays was assessed by evaluating 28 batches of rhGH drug substances with both methods. Finally, multiple batches of rhGH samples with different expiration dates were tested to determine the standard limits of the bioassay. The results of this collaborative study indicate that the Nb2-11 cell bioassay exhibits good intra- and inter-laboratory reproducibility, with a 100% pass rate for the experimental effective criteria. The Nb2-11 cell bioassay had high consistency with in vivo animal bioassay. Animal experiments were approved by the Experimental Animal Welfare Ethics Committee of China National Institute of Food and Drug Control (approval number: NIFDC (Fu) No. 2024 (B) 004). This method is applicable to rhGH drug substances and products from different manufacturers. Collectively, the Nb2-11 cell bioassay can be used as a standardized method for determining the biological activity of rhGH products, replacing in vivo animal methods for quality control and release testing.

recombinant human growth hormone  /  bioactivity  /  cell proliferation assay  /  method validation  /  collaborative validation
Xiao-ming ZHANG, He-yang LI, Zhe DENG, Nai-song QI, Xi WU, Yi LI, Lü-yin WANG, Ping LÜ, Cheng-gang LIANG, Jing LI. A collaborative study to evaluate the NB2-11 cell proliferation bioassay for human recombinant growth hormone[J]. Acta Pharmaceutica Sinica, 2025 , 60 (3) : 784 -790 . DOI: 10.16438/j.0513-4870.2024-0985
Year 2025 volume 60 Issue 3
PDF
246
122
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0985
  • Receive Date:2024-10-10
  • Online Date:2025-11-06
  • Published:2025-03-12
Article Data
Affiliations
History
  • Received:2024-10-10
  • Revised:2024-12-12
Funding
Affiliations
    1. NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, National Institutes for Food and Drug Control, Beijing 102629, China
    2. State Key Laboratory of Drug Regulatory Science, Beijing 102629, China
    3. College of Life Science, Jilin University, Changchun 130012, China
    4. Henan Institute for Drug and Medical Device Inspection, Henan Vaccine Issuance Center, Zhengzhou 450008, China
    5. Shenzhen Institute for Drug Control, Shenzhen 518057, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0985
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT